Houston, TEXAS -- Houston-based InformAI, a healthcare artificial intelligence (AI) startup, is pleased to join Johnson & Johnson Innovation - JLABS (JLABS), a 34,000-square-foot life science innovation center, in Houston’s Texas Medical Center (TMC).
JLABS is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world.
InformAI deploys AI-enabled solutions to assist physicians and healthcare organizations in speeding up diagnosis at the point of care, improving patient treatment planning and risk management.
InformAI is pleased to join JLABS @ TMC as a resident company in their growing global network of open innovation ecosystems that enable and empower innovators with the aim to create and accelerate the delivery of life-enhancing health and wellness solutions to patients around the world.
InformAI is proud to be one of the JLABS innovators using AI technology to change the standard of medical care. CEO Jim Havelka founded the company with the belief that Al will provide a paradigm shift for predictive analytic models within clinical medicine and healthcare operations.
InformAI is focused on a portfolio of novel AI healthcare solutions that support clinicians in medical specialties like the ENT field, thoracic surgery and cancer, and the company is right at home in the TMC. The company works closely with leading medical institutions within the Texas Medical Center, the world’s largest medical provider with 10 million patient encounters every year, and leading imaging/medical device companies.